V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210032767 | 210009030 | 1.84 | 95.3 | Curative (C) | 2014-11-01 | 2014-12-06 | UKALL14- Maintenance | 02 | N | 210017404 | UKALL2014 |
| 210032768 | 210009033 | 1.88 | 76 | Curative (C) | 2017-01-11 | 2017-02-20 | UKALL14- Intens/CNS Proph +Imatinib | N | N | 210017405 | UKALL2014 |
| 210032769 | 210009036 | 1.58 | 74 | Curative (C) | 2015-08-19 | 2015-09-27 | UKALL14- Cons Cycle 1 | Y | N | 210017421 | UKALL2014 |
| 210032770 | 210019716 | 1.71 | 93 | Curative (C) | 2017-01-12 | 2017-01-13 | UKALL14- Maintenance | Y | null | 210017422 | UKALL2014 |
| 210032771 | 210009043 | 1.83 | 94.499 | Curative (C) | 2014-03-15 | 2014-06-29 | UKALL14- Ph 2 Induction | N | N | 210017430 | UKALL2014 |
| 210032772 | 210009044 | 1.83 | 93.8 | Disease modification (D) | 2014-02-10 | 2014-05-19 | UKALL14- Intens/CNS Proph | 02 | N | 210017447 | UKALL2014 |
| 210032773 | 210009047 | 1.8 | 95.1 | Palliative (P) | 2014-07-15 | 2014-08-19 | UKALL14- Cons Cycle 1 | Y | N | 210017454 | UKALL2014 |
| 210032774 | 210009049 | 1.6 | 73.9 | Curative (C) | 2017-01-30 | 2017-02-01 | UKALL14- Maintenance | N | N | 210017455 | UKALL2014 |
| 210032775 | 210009055 | 1.89 | 68.3 | Curative (C) | 2016-01-24 | 2016-01-24 | UKALL 14 TRIAL | N | N | 210017476 | UKALL2014 |
| 210032776 | 210009061 | 1.72 | 87.3 | Curative (C) | 2014-07-16 | 2014-07-16 | UKALL14- Cons Cycle 3 + Imatinib | 02 | N | 210017484 | UKALL2014 |
| 210032777 | 210009062 | null | null | null | 2017-11-30 | 2017-12-02 | UKALL14- Maintenance | Y | N | 210017486 | UKALL2014 |
| 210032778 | 210009066 | 1.83 | 93.5 | Curative (C) | 2014-04-20 | 2014-11-22 | UKALL14- Ph 1 Induction | Y | N | 210017508 | UKALL2014 |
| 210032779 | 210030704 | 1.58 | 61.1 | Disease modification (D) | null | 2013-07-07 | UKALL14- Intens/CNS Proph +Imatinib | N | N | 210017512 | UKALL2014 |
| 210032780 | 210009070 | 1.89 | 79 | Curative (C) | null | 2013-11-12 | UKALL14- Maintenance | Y | null | 210017519 | UKALL2014 |
| 210032781 | 210009072 | 1.85 | 93.4 | Adjuvant (A) | 2017-02-25 | 2017-12-02 | UKALL14- Ph 2 Induction | N | null | 210017520 | UKALL2014 |
| 210032782 | 210009074 | 1.57 | 58.3 | Curative (C) | 2014-07-22 | 2014-07-30 | UKALL14- Maintenance | 2 | N | 210017522 | UKALL2014 |
| 210032783 | 210009077 | 1.82 | 79 | Disease modification (D) | 2014-02-28 | 2014-02-28 | UKALL 14 TRIAL | Y | N | 210017525 | UKALL2014 |
| 210032784 | 210009079 | null | 79 | Curative (C) | 2020-01-04 | 2020-01-06 | UKALL14- Ph 2 Induction | Y | null | 210017528 | UKALL2014 |
| 210032785 | 210019743 | 0 | 18.6 | Curative (C) | 2013-11-29 | 2013-11-29 | CNS Medbl Std Risk Maint Carbo | Y | N | 210017537 | NOT MATCHED |
| 210032786 | 210009084 | null | 7.9 | Curative (C) | 2015-10-18 | 2015-10-18 | CNS Epen2007 09 Baby Brn vinc+carbo | N | N | 210017538 | NOT MATCHED |
| 210032787 | 210009085 | 1.37 | 27.1 | Curative (C) | 2015-01-27 | 2015-01-27 | CNS Epen2007 09 Baby Brn vinc+Mtx | Y | null | 210017540 | NOT MATCHED |
| 210032788 | 210009089 | null | 16.1 | Curative (C) | 2017-04-05 | 2017-07-21 | CNS Headstart II Myeloablation | 02 | N | 210017549 | NOT MATCHED |
| 210032789 | 210009091 | 0.92 | 43.3 | Curative (C) | 2014-06-10 | 2015-03-06 | CNS Low Grade Glioma TPCV | Y | N | 210017557 | NOT MATCHED |
| 210032790 | 210009093 | 1.66 | 22 | Curative (C) | 2017-10-19 | 2017-11-25 | CNS PNET 5 Medbl L/StRsk Mnt A Cis | Y | N | 210017578 | NOT MATCHED |
| 210032791 | 210009093 | 0 | 15 | Curative (C) | 2016-11-15 | 2017-04-04 | CNS Infant MBL HDMTX | Y | N | 210017578 | NOT MATCHED |
| 210032792 | 210009094 | 0 | 12.4 | Curative (C) | 2014-05-11 | 2014-11-02 | CNS Headstart II Myeloablation | 1 | N | 210017590 | NOT MATCHED |
| 210032793 | 210009097 | 1.81 | 17.6 | Curative (C) | 2014-10-21 | 2014-12-18 | CNS Epen2007 09 Baby Brn vinc+Mtx | null | N | 210017602 | NOT MATCHED |
| 210032794 | 210026613 | 0 | 21.95 | Curative (C) | 2014-02-18 | 2014-05-14 | CNS Headstart II A Ind 4,5 int | N | N | 210017611 | NOT MATCHED |
| 210032795 | 210009101 | 0 | null | Curative (C) | 2013-12-10 | 2013-12-14 | CNS High Grade Glioma PCV | Y | N | 210017624 | NOT MATCHED |
| 210032797 | 210019758 | 0 | 28.5 | Curative (C) | 2018-04-17 | 2018-09-28 | CNS Epen2007 09 Baby Brn vinc+Mtx | Y | N | 210017642 | NOT MATCHED |
| 210032798 | 210009109 | 0 | 28 | Curative (C) | 2015-08-12 | 2016-02-09 | CNS Medbl St Risk <3yrs induction | Y | N | 210017645 | NOT MATCHED |
| 210032799 | 210019760 | null | 21.8 | Curative (C) | 2018-09-16 | 2018-10-23 | CNS Headstart II Myeloablation | Y | N | 210017647 | NOT MATCHED |
| 210032801 | 210009113 | 1.44 | 102.7 | Curative (C) | 2016-03-11 | 2016-05-07 | CNS ATRT ICE | Y | null | 210017657 | NOT MATCHED |
| 210032802 | 210009116 | null | 37 | Curative (C) | 2014-10-02 | 2014-10-10 | CNS High Grade Glioma PCV | Y | null | 210017673 | NOT MATCHED |
| 210032803 | 210009120 | null | 82.1 | Disease modification (D) | 2018-02-06 | 2018-02-07 | CNS High Grade Glioma PCV | 1 | null | 210017682 | NOT MATCHED |
| 210032804 | 210009123 | 1.49 | 83.8 | Curative (C) | 2017-09-06 | 2017-12-16 | CNS Epen2007 09 Baby Brn vinc+Mtx | Y | null | 210017684 | NOT MATCHED |
| 210032806 | 210009128 | null | 13.6 | Curative (C) | 2017-03-01 | 2017-03-01 | CNS ATRT Methotrexate Intrathecal | Y | null | 210017716 | NOT MATCHED |
| 210032807 | 210009130 | 1.07 | 4.5 | Curative (C) | 2017-03-10 | 2017-03-31 | CNS Epen2007 09 Baby Brn cisplatin | Y | N | 210017736 | NOT MATCHED |
| 210032808 | 210009131 | 1.06 | 26.3 | Palliative (P) | 2017-07-30 | 2017-07-30 | CNS PNET 5 Medbl L/StRsk Mnt B | N | null | 210017743 | NOT MATCHED |
| 210032809 | 210009133 | null | 14.2 | Curative (C) | 2015-12-24 | 2016-04-01 | ALL UKALL2003 A: Ph VII Maint wk39+ | N | N | 210017747 | NOT MATCHED |
| 210032810 | 210019777 | null | 9.1 | Curative (C) | 2017-12-08 | 2018-01-15 | NB Rel CCLG guidelines Cyclo-Topotecan | N | N | 210017750 | NOT MATCHED |
| 210032811 | 210009137 | 0 | 10.8 | Curative (C) | 2017-12-07 | 2017-12-08 | CNS Medbl HR Carboplatin/Vinc/Cyclophos/GCSF | null | N | 210017755 | NOT MATCHED |
| 210032812 | 210019780 | null | 15.7 | Curative (C) | 2014-02-27 | 2014-04-13 | CNS Headstart II A Ind 1,2,3 int | Y | N | 210017768 | NOT MATCHED |
| 210032813 | 210009140 | 1.75 | 47.45 | Curative (C) | 2013-12-28 | 2014-01-08 | CYCLOPHOSPHAMIDE + ETOPOSIDE + PEGASPARAGINASE | Y | N | 210017772 | NOT MATCHED |
| 210032815 | 210009144 | null | 24.6 | Radical (R) | 2014-07-05 | 2014-07-09 | PNET 4 HIT-SIOP Chemo + RT | N | N | 210017779 | NOT MATCHED |
| 210032817 | 210009148 | null | 59.2 | Curative (C) | 2018-01-11 | 2018-01-11 | CNS ATRT VCA | N | N | 210017790 | NOT MATCHED |
| 210032818 | 210009149 | 1.4 | null | Curative (C) | 2013-12-16 | 2013-12-22 | CNS LGG2004 03 vinc + carbo | N | null | 210017796 | NOT MATCHED |
| 210032819 | 210009156 | null | 23.8 | Disease modification (D) | 2016-02-18 | 2016-09-01 | AML Interim Guidelines | N | N | 210017840 | NOT MATCHED |
| 210032820 | 210009156 | 0 | null | Curative (C) | 2013-02-05 | 2013-03-30 | ALL ALLR3: S/IR: Intens Wk 9-11 | 01 | N | 210017840 | NOT MATCHED |
| 210032821 | 210009160 | null | 6.6 | Adjuvant (A) | null | 2015-01-24 | CNS Medbl HR Etoposide | 1 | N | 210017843 | NOT MATCHED |